A Single-blind Crossover Study of the Pharmacokinetic and Postprandial Glucose Dynamics of BIOD-531 Compared to Humulin R U-500 and Humalog Mix75/25 in Subjects With Type 2 DM Who Are Treated With ≥ 150 Units of Insulin Per Day
Phase of Trial: Phase I/II
Latest Information Update: 12 Feb 2016
At a glance
- Drugs Insulin (Primary) ; Insulin neutral protamine lispro/insulin lispro
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Biodel
- 12 Feb 2016 Last checked against ClinicalTrials.gov record.
- 14 Sep 2015 According to a Biodel media release, results from this study will be presented at the 51st Annual Meeting of the European Association for the Study of Diabetes (EASD).
- 09 Jun 2015 Results (pre- and post-prandial blood glucose concentrations) presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History